热休克蛋白90介导γ干扰素诱导的对抗程序性死亡蛋白1免疫疗法的适应性抗性。
HSP90 Mediates IFNγ-Induced Adaptive Resistance to Anti-PD-1 Immunotherapy.
作者信息
Liu Ke, Huang Jun, Liu Jiao, Li Changfeng, Kroemer Guido, Tang Daolin, Kang Rui
机构信息
Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, China.
Department of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, China.
出版信息
Cancer Res. 2022 May 16;82(10):2003-2018. doi: 10.1158/0008-5472.CAN-21-3917.
Abstract
This study reveals an HSP90-centric, iron-modulated mechanism that confers immunosuppression, offering potential therapeutic targets for interfering with acquired resistance to the most prevalent anticancer immunotherapies.
摘要
这项研究揭示了一种以热休克蛋白90（HSP90）为中心、铁调节的免疫抑制机制，为干扰对最常见抗癌免疫疗法的获得性耐药提供了潜在的治疗靶点。
Zotero 插件